Loading...

IONQ IONQ INC US FDA Inspections 8-K Filing

NQ N

NQ

IONQ INC

(IONQ)

2025 8-K

Board Appointment

Stock Resale Filing

Financial Results Release

Acquisition Completion

Merger Announcement

CFO Separation Details

Management Changes

Stock Resale Filing

Financial Results Report

Stock Resale Filing

Stock Resale Filing

Stock Offering Announcement

IonQ Acquisition Report

Director Appointment

Acquisition Announced

Company Acquisitions

Management Change

Stock Resale Filed

New Board Appointments

Executive Compensation Update

Financial Statements

Merger of Equals

Equity Offerings

Primary Offerings

Asset Acquisitions

Asset Acquisitions

Financial Statements

Asset Acquisitions

Bylaw Amendments

Agreement Termination

Acquisition Update

Equity Offering

Leadership Changes

Executive Compensation

Severance Plan Update

Q3 Financial Results

Executive Vote Frequency

Financial Results Announcement

Annual Meeting Results

Earnings Reports

Results of Operations and F...

Financial Results Announcement

Resignation of Director

Departure of Directors or C...

Financial Results and Depar...

Annual Meeting Results

Earnings Reports

Financial Results Announcement

Earnings Reports

Petition for Validation of ...

External Links:

On November 10, 2025, IonQ, Inc. filed a prospectus supplement for the resale of 2,108,993 shares of common stock as part of a Registration Rights Agreement with The University of Chicago, effective November 10, 2025.

AI Assistant

IONQ INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.